CSL

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis, and nephrology. Since their start in 1916, they have been driven by their promise to save lives using the latest technologies. Today, CSL – including their businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Their unique combination of commercial strength, R&D focus, and operational excellence enables them to identify, develop, and deliver innovations so their patients can live life to the fullest. See their community guidelines: https://bit.ly/3Bs17Ra